[Brainlife] Methodology

Overall Management > Methodology

Reporting

	Susan M. Chang, Sharon L. Reynolds, Nicholas Butowski, Kathleen R. Lamborn, Jan C. Buckner, Richard S. Kaplan, and Darell D. Bigner GNOSIS: Guidelines for neuro-oncology: Standards for investigational studies—reporting of phase 1 and phase 2 clinical trials Neuro-oncol 2005; 7(4): 425-434; DOI:10.1215/S1152851705000554 Reprint \| DBLinks

Brain Tumors

	Ramsis K. Benjamin,1 Fred H. Hochberg, Elizabeth Fox, Peter M. Bungay, William F. Elmquist, Clinton F. Stewart, James M. Gallo, Jerry M. Collins, Robert P. Pelletier, John F. de Groot, Robert C. Hickner, Idil Cavus, Stuart A. Grossman, and O. Michael Colvin Review of microdialysis in brain tumors, from concept to application: First Annual Carolyn Frye-Halloran Symposium Neuro-Oncology, January 2004, Volume 6, Number 1, Pages: 65 -- 74 (Review Article, Abstract+)
	Carson BS Sr, Wu Q, Tyler B, Sukay L, Raychaudhuri R, DiMeco F, Clatterbuck RE, Olivi A, Guarnieri M New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery J Neurooncol 2002 Nov;60(2):151-8 (Animal Study, Abstract)
	Frederick F. Lang, Anthony Asher Prospective Clinical Trials of Brain Tumor Therapy: The Critical Role of Neurosurgeons J Neurooncol, 69(1):151-167, Aug-Sept 2004. (Review Article, Abstract+)
	E. G. Rivarola, G. L. Chantada, L. Ezcurdia, A. Negro, E. Gil Deza, D. Cascallar, D. Santillán, S. Carnaval, E. Morgenfeld, F. G. Gercovich Adherence to standard therapy for the treatment of childhood CNS tumors in Argentina. An audit perspective 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8573 (Retrospective Study)
	Mark L. Rosenblum, Tom Mikkelsen Developing a Brain Tumor Center J Neurooncol, 69(1):169-180, Aug-Sept 2004. (Review Article, Abstract+)

Germ Cell Tumors

	Kochi M, Itoyama Y, Shiraishi S, Kitamura I, Marubayashi T, Ushio Y Successful treatment of intracranial nongerminomatous malignant germ cell tumors by administering neoadjuvant chemotherapy and radiotherapy before excision of residual tumors J Neurosurg. 2003 Jul;99(1):106-14 (Clinical Study, Abstract)

Glioblastoma

	K. V. Ballman, K. A. Jaeckle, P. D. Brown, P. J. Flynn and J. C. Buckner NCCTG N047D: Relationship between phase II endpoints of 12 month overall survival and 6 month progression-free survival for glioblastoma multiforme (GBM) phase II trials 2005 ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1508. (Clinical Investigation) Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005: 1508
	Markus Bredel, Claudia Bredel, Hannes Vogel, Griffith Harsh IV, Branimir I. Sikic Multiple displacement amplification-based comprehensive genome amplification in fresh-frozen and formalin-fixed/paraffin-embedded clinical brain tumor samples Proceedings of the AACR, Volume 45, March 2004, Abstract Number: 5238. (Laboratory Investigation)
	Hochberg FH, Pruitt A Assumptions in the radiotherapy of glioblastoma Neurology. 1980 Sep; 30(9): 907-11. (Retrospective Study, Abstract)
	Karl F. Schmidt, Mateo Ziu, Nils Ole Schmidt, Pramil Vaghasia, Theresa G. Cargioli, Sameer Doshi, Mitchell S. Albert, Peter McL. Black, Rona S. Carroll, Yanping Sun Volume Reconstruction Techniques Improve the Correlation Between Histological and in vivo Tumor Volume Measurements in Mouse Models of Human Gliomas Journal of Neuro-Oncology, 68 (3): 207-215, July 2004 (Animal Study, Abstract+)

Gliomas

	Corinne Bouvier, Patrice Roll, Benoit Quilichini, Philippe Metellus, Arlette Calisti, Sophie Gilles, Olivier Chinot, Frederic Fina, Pierre M. Martin, Dominique Figarella-Branger Deletions of Chromosomes 1p and 19q are Detectable on Frozen Smears of Gliomas by FISH: Usefulness for Stereotactic Biopsies Journal of Neuro-Oncology, 68 (2): 141-149, June 2004. (Laboratory Investigation, Abstract+)
	Emmanuelle Di Tomaso, Edward Brown, Yotaro Izumi, Rakesh K. Jain A novel, orthotopic model of glioblastoma growth and invasion for intravital microscopy Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2956 (Cell Culture Study)
	Ferrari M, Cremonesi M, Bartolomei M, Bodei L, Chinol M, Fiorenza M, Tosi G, Paganelli G Dosimetric Model for Locoregional Treatments of Brain Tumors with 90Y-Conjugates: Clinical Application with 90Y-DOTATOC J Nucl Med. 2006 Jan;47(1):105-12. (Clinical Study, Abstract)
	A. Flowers Management of malignant gliomas at Hartford Hospital: Patterns of care and outcomes 39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 464 (Clinical Study)
	Sophie Godard, Gad Getz, Hiroyuki Kobayashi, Pierre Farmer, Mauro Delorenzi, Annie-Claire Diserens, Marie-France Hamou, Roger Stupp, Robert Janzer, Philipp Bucher, Eytan Domany, Nicolas de Tribolet, Monika E. Hegi Tumor classifier for human gliomas based on gene expression profiles Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 1036 (Cell Culture Study)
	Tsugumichi Ichioka, Shin-Ichi Miyatake, Naoki Asai, Yoshinaga Kajimoto, Toshimasa Nakagawa, Hideyuki Hayashi and Toshihiko Kuroiwa Enhanced detection of malignant glioma xenograft by fluorescein-human serum albumin conjugate J Neurooncol. 2004 Mar-Apr;67(1-2):47-52. (Laboratory Investigation, Abstract+)
	Lamborn KR, Yung WK, Chang SM, Wen PY, Cloughesy TF, Deangelis LM, Robins HI, Lieberman FS, Fine HA, Fink KL, Junck L, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Hibberts J, Peterson PM, Prados MD. Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas Neuro Oncol. 2008 Mar 4; [Epub ahead of print] Abstract \| DBLinks \| BL 7:7
	Levin VA, Ictech S, Hess KR. Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas. BMC Cancer. 2007 Jun 22;7(1):106 [Epub ahead of print] PMID: 17587447 [PubMed - as supplied by publisher]
	Christoph Mamot, John B. Nguyen, Micheal Pourdehnad, Piotr Hadaczek, Ryuta Saito, John R. Bringas, Daryl C. Drummond, Keelung Hong, Dmitri B. Kirpotin, Tracy McKnight, Mitchel S. Berger, John W. Park, Krys S. Bankiewicz Extensive Distribution of Liposomes in Rodent Brains and Brain Tumors Following Convection-Enhanced Delivery Journal of Neuro-Oncology, 68 (1): 1-9, May 2004. (Animal Study, Abstract+)
	Schwartz SA, Weil RJ, Thompson RC, Shyr Y, Moore JH, Toms SA, Johnson MD, Caprioli RM Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry Cancer Res. 2005 Sep 1;65(17):7674-81. (Laboratory Investigation, Abstract)
	G. Shah, S. Kesari, R. Xu, J. Henson, T. Batchelor, F. Hochberg, A. Oneill, B. Levy, J. Bradshaw, P. Y. Wen Comparison of 1D, 2D, 3D and volumetric parameters in measuring tumor response in high-grade gliomas in adults 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1523 (Clinical Study)
	Smilowitz HM, Weissenberger J, Weis J, Brown JD, O'Neill RJ, Laissue JA. Orthotopic transplantation of v-src-expressing glioma cell lines into immunocompetent mice: establishment of a new transplantable in vivo model for malignant glioma. J Neurosurg. 2007 Apr;106(4):652-9. PMID: 17432718 [PubMed - in process]
	Michael Vavra, M. Jaffer Ali, Eric W.-Y. Kang, Yot Navalitloha, Allison Ebert, Cathleen V. Allen, Dennis R. Groothuis Comparative pharmacokinetics of ¹⁴C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery Neuro-Oncology, April 2004, Volume 6, Number 2, Pages 104 – 112. (Laboratory Investigation, Abstract+)
	Yi-Hong Zhou, Kenneth R. Hess, W. K. Alfred Yung Prognostic model for glioma patients Proceedings of the AACR, Volume 45, March 2004, Abstract Number: 1078. (Laboratory Investigation)
	Zhao JX, Yang LP, Wang YF, Qin LP, Liu DQ, Bai CX, Nan X, Shi SS, Pei XJ. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells. Eur J Neurol. 2007 May;14(5):510-6. PMID: 17437609 [PubMed - in process]

Medulloblastoma

	Saunders DE, Hayward RD, Phipps KP, Chong WK, Wade AM Surveillance neuroimaging of intracranial medulloblastoma in children: how effective, how often, and for how long? J Neurosurg. 2003 Aug;99(2):280-6 (Retrospective Study, Abstract)

Metastatic Tumors

	M. T. Carpenter, J. C. Flickinger, M. A. Quader, C. E. Miles Improvements in technique for whole-brain irradiation 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1539 (Clinical Study)
	S. Kahl, R. A. Sala, L. Mengelle, M. Alarcón, L. E. Fein Application of the Edmonton Functional Assessment Tool (EFAT) in patients with brain metastases (BM) treated only with palliative radiotherapy (PRT) 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8054 (Clinical Study)

Neuroblastoma

	H Rubie, C Coze, D Plantaz, C Munzer, A S Defachelles, C Bergeron, C Thomas, P Chastagner, D Valteau-Couanet, J Michon, V Mosseri and O Hartmann Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy British Journal of Cancer, 3 November 2003, Volume 89, Number 9, 1605-1609 (Clinical Study, Abstract)

Non-Nervous System Tumors

	M. Weyl Ben Arush, M. Haimi, M. Peretz Nahum, H.F. Rennert, K. KatzDelay in diagnosis of children with cancer: a retrospective study of 315 children ECCO 12 - the European Cancer Conference Copenhagen, Denmark, 21-25 September 2003. Abstract No. 640 European Journal of Cancer Supplements; Vol. 1, No. 5, September 2003, page S192 (Retrospective Study)
	P.G. Casali, L. Ciccolallo, R. Capocaccia, P. Bruzzi, L. Licitra, F. Grosso, F. Berrino, G. Gatta A definition of what a rare tumor is ECCO 12 - the European Cancer Conference Copenhagen, Denmark, 21-25 September 2003. Abstract No. 1046 European Journal of Cancer Supplements; Vol. 1, No. 5, September 2003, page S312 (Retrospective Study)
	Miller AB, Hoogstraten B, Staquet M, Winkler A Reporting results of cancer treatment Cancer. 1981 Jan 1; 47(1): 207-14. (Report on Standardization Techniques, Abstract)
	Gary L. Rosner, Walter Stadler, Mark J. Ratain Randomized Discontinuation Design: Application to Cytostatic Antineoplastic Agents Journal of Clinical Oncology, Vol 20, Issue 22 (November), 2002: 4478-4484 (Clinical Study Design, Abstract)
	Therasse P Measuring the clinical response. What does it mean? Eur J Cancer 2002 Sep;38(14):1817-23 (Review Article, Abstract)

Pediatric Brain Tumors

	Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P International Classification of Childhood Cancer, third edition Cancer. 2005 Apr 1;103(7):1457-67. (Clinical Investigation, Abstract)

Tools

	Pierre Chaurand, Sarah A. Schwartz, Michelle L. Reyzer, and Richard M. Caprioli Imaging Mass Spectrometry: Principles and Potentials Toxicologic Pathology, Jan 2005; vol. 33: pp. 92 - 101 Abstract \| Reprint \| DBLinks \| BL 7:8